Search results
Results From The WOW.Com Content Network
Cell potency is a cell's ability to differentiate into other cell types. [1] [2] The more cell types a cell can differentiate into, the greater its potency.Potency is also described as the gene activation potential within a cell, which like a continuum, begins with totipotency to designate a cell with the most differentiation potential, pluripotency, multipotency, oligopotency, and finally ...
Immune monitoring of subjects through one year post-transplantation showed no evidence of antibody-based or cellular immune responses to AST-OPC1. In four of the five subjects, serial MRI scans performed throughout the 2–3 year follow-up period indicate that reduced spinal cord cavitation may have occurred and that AST-OPC1 may have had some ...
The liver receptor homolog-1 (LRH-1) also known as totipotency pioneer factor NR5A2 (nuclear receptor subfamily 5, group A, member 2) is a protein that in humans is encoded by the NR5A2 gene. [ 5 ] [ 6 ] LRH-1 is a member of the nuclear receptor family of intracellular transcription factors .
Totipotency. 17 languages. ... Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply. By using this site, ...
Cellular differentiation is the process in which a stem cell changes from one type to a differentiated one. [ 2 ] [ 3 ] Usually, the cell changes to a more specialized type. Differentiation happens multiple times during the development of a multicellular organism as it changes from a simple zygote to a complex system of tissues and cell types.
Within an embryo, several processes play out at the cellular and tissue level to create an organism. These processes include cell proliferation, differentiation, cellular movement [1] and programmed cell death. [2] [3] Each cell in an embryo receives molecular signals from neighboring cells in the form of proteins, RNAs and even surface ...
The term stem cell was coined by Theodor Boveri and Valentin Haecker in late 19th century. [8] Pioneering works in theory of blood stem cell were conducted in the beginning of 20th century by Artur Pappenheim, Alexander A. Maximow, Franz Ernst Christian Neumann.
It is also clear that pro-mitotic factors such as C-MYC/L-MYC or repression of cell cycle checkpoints, such as p53, are conduits to creating a compliant cellular state for iPSC reprogramming. [ 12 ] iPSC derivation is typically a slow and inefficient process, taking one–two weeks for mouse cells and three–four weeks for human cells, with ...